Cliff Asness
Cliff Asness's Q2 2026 quarterly filing logged 30 moves — the largest single-quarter reshuffle on record with us (since 2024-Q3) at $82.7B.
- Largest single-quarter reshuffle on record with us — $82.7B
- Added to NVDA for a 7th consecutive quarter
- New $359.9M position in JAZZ
Sources & details
Windowpast 90 days · 30 events · ending Sep 11, 2026
DetailLargest single-quarter reshuffle on record with us — $82.7B (since 2024-Q3) · Added to NVDA for a 7th consecutive quarter (+5.7M shares in 2026-Q2) · New $359.9M position in JAZZ — <1% of portfolio · New $234.0M position in ROIV — <1% of portfolio · Added $138.5M to NEU — <1% of portfolio, +128% QoQ
Full summary
Cliff Asness's Q2 2026 quarterly filing represented the largest single-quarter reshuffle on record with us — $82.7B (since 2024-Q3) — spanning 30 disclosed position changes across a wide range of sectors and market caps. The most prominent new positions opened in the quarter included Jazz Pharmaceuticals (JAZZ) at $359.9M and Roivant Sciences (ROIV) at $234.0M, both in the healthcare space. Additional new stakes were established in WEC Energy (WEC) at $67.8M, UDR Inc. (UDR) at $40.3M, Nabors Industries (NBR) at $25.5M, and several smaller names including WTI, TMDX, SLDB, RZLV, and BRSL. On the reduction side, LYFT was trimmed by $76.7M (−67% QoQ), representing the most visible single cut in the window. CVI was also reduced by 77% QoQ. Among additions to existing positions, NEU received +$138.5M (+128% QoQ), ELS was added to at +238% QoQ, and IAG grew +136% QoQ. GIS received a modest +$39.2M addition (+15% QoQ). The breadth of this quarter's activity — new healthcare platforms, utility names, real estate investment trusts, and small-cap positions opened alongside targeted trims — reflects the scale of rebalancing that defines AQR's systematic, factor-driven approach across its disclosed equity book.
Source19 citations →
GeneratedSep 11, 2026
NoteAuto-generated summary · not investment advice · verify before acting.